Skip to Main Content

The (POGO) Blog

April 6, 2017

By Ari Goldberg

POGO Calls for Clarification on Devin Nunes House Intel Committee Shakeup



Devin Nunes Devin Nunes' temporary step aside from an investigation into Russian meddling into the 2016 election is "a step in the right direction" but more clarification is needed, says POGO Executive Director Danielle Brian.

Continue Reading POGO Calls for Clarification on Devin Nunes House Intel Committee Shakeup

Topics: Government Accountability

April 5, 2017

By Daniel Van Schooten

Congressional Letters to Agencies Going Unanswered



Congress Over 100 of Congress’s letters to the Trump administration have gone unanswered. POGO urges President Trump to take Congressional oversight seriously and quickly fill vacant Congressional affairs positions.

Continue Reading Congressional Letters to Agencies Going Unanswered

Topics: Government Accountability

April 3, 2017

By David S. Hilzenrath

Questions for Trump’s FDA Nominee



Scott Gottlieb President Donald Trump’s nominee to head the Food and Drug Administration has deep roots in the pharmaceutical industry he would oversee.

Continue Reading Questions for Trump’s FDA Nominee

Topics: Public Health and Science

March 13, 2017

By Nick Schwellenbach

Trump’s Trademarks Pose Ethics Challenge for the Executive Branch



Trump President Trump has trademark litigation before an executive branch panel—these judges ultimately work for Trump. Can they neutrally preside over a case involving him?

Continue Reading Trump’s Trademarks Pose Ethics Challenge for the Executive Branch

Topics: Government Accountability

March 3, 2017

By David S. Hilzenrath

Trump’s Dangerous Prescription for the FDA



President Trump addressing a joint session of Congress, with VP Mike Pence and Rep. Paul Ryan seated behind him, clapping. President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.

Continue Reading Trump’s Dangerous Prescription for the FDA

Topics: Government Accountability, Open Government, Public Health and Science

Items 26 - 30 of 81  Previous12345678910Next

Browse POGOBlog by Topic

POGO on Facebook